# IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE

> **NCT04124367** · PHASE2 · TERMINATED · sponsor: **Ever Neuro Pharma GmbH** · enrollment: 4 (actual)

## Conditions studied

- Chronic Stroke
- Subacute Stroke

## Interventions

- **DRUG:** Cerebrolysin
- **DEVICE:** non-invasive brain stimulation
- **DRUG:** Placebo
- **DEVICE:** sham intervention

## Key facts

- **NCT ID:** NCT04124367
- **Lead sponsor:** Ever Neuro Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-25
- **Primary completion:** 2022-03-21
- **Final completion:** 2022-03-21
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** for strategic and pandemic reasons
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124367, "IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04124367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*